Tom Johnsson News Today

While ashwagandha investment and innovation is surging, some European authorities are showing signs of safety concern, leading industry experts to criticize a spread of "complete misinformation" across the continent.

The industry has vehemently rejected a regulatory assessment leading to the ban of ashwagandha in Denmark and defended the ingredient's safety, as an increasing number of member states show concerns.

The industry has vehemently rejected a regulatory assessment leading to the ban of ashwagandha in Denmark and defended the ingredient's safety, as an increasing number of member states show concerns.

The industry has vehemently rejected a regulatory assessment leading to the ban of ashwagandha in Denmark and defended the ingredient's safety, as an increasing number of member states show concerns.

Part one of four articles detailing the harvesting, processing, testing and clinical research behind one of today’s most popular medicinal botanicals.